Kaya Holdings (Kaya Holdings) Debt-to-Revenue : 61.33 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Kaya Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Kaya Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.28 Mil. Kaya Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $8.06 Mil. Kaya Holdings's annualized Revenue for the quarter that ended in Dec. 2023 was $0.14 Mil. Kaya Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 61.33.

Kaya Holdings Debt-to-Revenue Historical Data

The historical data trend for Kaya Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaya Holdings Debt-to-Revenue Chart

Kaya Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

6.49

7.23

8.43

11.49

42.56

Kaya Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial															15.26	39.88	36.08	34.34	61.33

Competitive Comparison of Kaya Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Kaya Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaya Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaya Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kaya Holdings's Debt-to-Revenue falls into.

Kaya Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Kaya Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.28	+	8.061)	/	0.196
	=	42.56

Kaya Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.28	+	8.061)	/	0.136
	=	61.33

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.

Kaya Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kaya Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaya Holdings (Kaya Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaya Holdings Inc (OTCPK:KAYS) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

915 Middle River Drive, Suite 316, Fort Lauderdale, FL, USA, 33304

Website

https://www.kayaholdings.com

Kaya Holdings Inc is a holding company. It pursues medical and recreational licenses for the growing, processing, and sale of marijuana in jurisdictions through its subsidiaries. The company owns and operates brands that produce, distribute, and sell premium cannabis products including flowers, concentrates, and cannabis-infused baked goods and candies. It mainly operates a vertically integrated seed-to-sale legal marijuana enterprise and its operations include medical marijuana dispensaries, medical marijuana grow-operations, the manufacturing of proprietary cannabis products, and research and development of medical-grade cannabis strains and extracts for pain relief and treatment of serious illnesses. The company operates the Kaya Shack brand of medical marijuana dispensaries.